'Pharm Bro' Shkreli hit with gag order

In granting the gag order, Judge Matsumoto directed Shkreli to stop talking in and around the courthouse.
By James Smith | Jul 08, 2017
The federal judge in Martin Shkreli's securities fraud trial has ordered him to stop commenting publicly about the proceeding after the notorious pharmaceutical executive spoke to reporters for five minutes last week.

"I was shocked that there were these comments, these statements," said Judge Kiyo Matsumoto, as reported by CNBC. "There's a great risk jurors will be exposed."

In their motion for a gag order filed Monday night, prosecutors said they believed Shkreli had resumed posting on Twitter, which canceled his account after he wrote harassing tweets directed at a female journalist. They said a new account with the new handle @BLMBro contained postings about the ongoing trial and were written in Shkreli's confrontational style.

Twitter suspended the @BLMBro account after learning of the prosecutors' motion.

In granting the gag order, Judge Matsumoto directed Shkreli to stop talking in and around the courthouse.

"I would like to so order the agreement that he will not make comments in the courthouse about the evidence and the witnesses and this also includes the perimeter roads," the judge said. "I think it's inappropriate and that all the work we've done to select 18 men and women to sit on the jury would be jeopardized if he continued to do this."

Prosecutors also contradicted Shkreli's assertion made to reporters last week that he has never considered a plea agreement.

Shkreli is charged with securities fraud for allegedly ripping off millions of dollars from Retrophin, the publicly traded drug company he founded.

---

Have something to say? Let us know in the comments section or send an email to the author. You can share ideas for stories by contacting us here.

Comments
Comments should take into account that readers may hold different opinions. With that in mind, please make sure comments are respectful, insightful, and remain focused on the article topic.